Isoquinolines and derivatives
Sigma Aldrich Fine Chemicals Biosciences Endothelin 1 97 HPLC powde
Endothelin-1 (ET-1) is synthesized and secreted by activated endothelial cells and is a peptide with potent vasoconstrictor activity. It is a marker for activated or dysfunctional endothelial cells. This peptide is one of the three isopeptides belonging to the endothelin family. It is also released by cardiomyocytes.
Apexbio Technology LLC Atracurium Besylate 64228-81-5 10mM (in 1mL DMSO)
Atracurium Besylate (CAS 64228-81-5) is a non-depolarizing neuromuscular blocking agent that exerts its effects by competitively inhibiting acetylcholine receptors at the neuromuscular junction thereby interrupting neurotransmission between motor nerves and skeletal muscle In biomedical research it is utilized to induce neuromuscular blockade enabling studies of neurotransmitter release synaptic transmission mechanisms and regulation of muscle contraction Additionally Atracurium Besylate has been reported to elicit bronchoconstriction and promote differentiation of glial cells such as astrocytes supporting investigations into cellular differentiation and airway responsiveness
Apexbio Technology LLC Atracurium Besylate 64228-81-5 100mg
Atracurium Besylate (CAS 64228-81-5) is a non-depolarizing neuromuscular blocking agent that exerts its effects by competitively inhibiting acetylcholine receptors at the neuromuscular junction thereby interrupting neurotransmission between motor nerves and skeletal muscle In biomedical research it is utilized to induce neuromuscular blockade enabling studies of neurotransmitter release synaptic transmission mechanisms and regulation of muscle contraction Additionally Atracurium Besylate has been reported to elicit bronchoconstriction and promote differentiation of glial cells such as astrocytes supporting investigations into cellular differentiation and airway responsiveness
Apexbio Technology LLC Atracurium Besylate 64228-81-5 500mg
Atracurium Besylate (CAS 64228-81-5) is a non-depolarizing neuromuscular blocking agent that exerts its effects by competitively inhibiting acetylcholine receptors at the neuromuscular junction thereby interrupting neurotransmission between motor nerves and skeletal muscle In biomedical research it is utilized to induce neuromuscular blockade enabling studies of neurotransmitter release synaptic transmission mechanisms and regulation of muscle contraction Additionally Atracurium Besylate has been reported to elicit bronchoconstriction and promote differentiation of glial cells such as astrocytes supporting investigations into cellular differentiation and airway responsiveness
Apexbio Technology LLC Atracurium Besylate 64228-81-5 50mg
Atracurium Besylate (CAS 64228-81-5) is a non-depolarizing neuromuscular blocking agent that exerts its effects by competitively inhibiting acetylcholine receptors at the neuromuscular junction thereby interrupting neurotransmission between motor nerves and skeletal muscle In biomedical research it is utilized to induce neuromuscular blockade enabling studies of neurotransmitter release synaptic transmission mechanisms and regulation of muscle contraction Additionally Atracurium Besylate has been reported to elicit bronchoconstriction and promote differentiation of glial cells such as astrocytes supporting investigations into cellular differentiation and airway responsiveness
Medchemexpress LLC Atracurium (besylate) | 64228-81-5 | 98.6% | 500 MG
Atracurium besylate is a potent, competitive, and non-depolarizing neuromuscular blocking agent. It also acts as an AChR receptor antagonist, inducing bronchoconstriction and neuromuscular blockade, and promoting astroglial differentiation.
- Potent, competitive, and non-depolarizing neuromuscular blocking agent
- AChR receptor antagonist
- Induces bronchoconstriction and neuromuscular blockade
- Promotes astroglial differentiation
- Reduces tumor engraftment in xenotransplanted GSCs
- Induces a complete fade of tetanic contraction in rat muscle cells